BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22950965)

  • 1. An audit of pneumococcal and hepatitis vaccination in an outpatient HIV clinic.
    Hunter MG; Post JJ
    Sex Health; 2012 Nov; 9(5):495-6. PubMed ID: 22950965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?
    Jimenez HR; Hallit RR; Debari VA; Slim J
    Vaccine; 2013 Feb; 31(9):1328-33. PubMed ID: 23277097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
    Tenner CT; Herzog K; Chaudhari S; Bini EJ; Weinshel EH
    Int J Clin Pract; 2012 Oct; 66(10):1009-13. PubMed ID: 22994334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are liver transplant recipients protected against hepatitis A and B?
    Andersson D; Castedal M; Friman V
    Transplant Proc; 2013 Apr; 45(3):1193-7. PubMed ID: 23622657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis vaccination and infection among gay, bisexual, and other men who have sex with men who attend gyms in New York City.
    Siconolfi DE; Halkitis PN; Rogers ME
    Am J Mens Health; 2009 Jun; 3(2):141-9. PubMed ID: 19477727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twinrix vaccination schedules among injecting drug users.
    Brim N; Zaller N; Taylor LE; Feller E
    Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of humoral response to recommended vaccines in HIV-infected adults.
    Tsachouridou O; Christaki E; Skoura L; Georgiou A; Nanoudis S; Vasdeki D; Ntziovara MA; Kotoreni G; Forozidou E; Tsoukra P; Germanidis G; Metallidis S
    Comp Immunol Microbiol Infect Dis; 2017 Oct; 54():27-33. PubMed ID: 28915998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.